Literature DB >> 12624431

The expression of angiotensin and endothelin system members in bovine corpus luteum during estrous cycle and pregnancy.

Bajram Berisha1, Dieter Schams, Akio Miyamoto.   

Abstract

The aim of this study was to determine the changing profiles of the mRNA expression of members of angiotensin and endothelin system in bovine corpus luteum (CL) from different stages of the estrous cycle and pregnancy. Corpora lutea were accordingly assigned to the following stages; d 1 2, 3 4, 5 7, 8 12, 13 18, >18 (after regression) of estrous cycle and of early and late pregnancy (<4 and >4 mo). The block RT-PCR analysis of CL showed a significantly higher angiotensin converting enzyme (ACE) mRNA expression during mid and late luteal phases as well as after regression, but lower levels during pregnancy. Full quantitative real-time RT-PCR (LightCycler) confirmed this pattern of ACE mRNA expression. The angiotensin receptor type 1 (AT1R) mRNA expression was relatively stable throughout the periods examined. In contrast, AT2R mRNA temporarily decreased on d 8 12, followed by an increase to the highest levels during late luteal phase, and it remained at high levels during regression and pregnancy. Concentration of angiotensin II (Ang II) peptide in luteal tissue was highest after ovulation (d 1 2), decreased afterward, increased again during late luteal phase, and decreased to lower levels during regression and pregnancy. The mRNA expression and peptide concentration of endothelin 1 (ET-1) was high after ovulation followed by a decrease during mid and late luteal phases and increased again to the highest level after regression. The endothelin receptor type B (ETR-B) mRNA expression increased during late luteal phase and further after regression. In contrast, ETR-A and endothelin converting enzyme 1 (ECE-1) mRNA expression were relatively constant during all stages examined. In conclusion, the regulatory changes of both angiotensin and endothelin family members during early luteal phase and again during late luteal phase suggest a possible modulatory role of these vasoactive peptide families for bovine CL formation and regression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12624431     DOI: 10.1385/ENDO:19:3:305

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  41 in total

1.  Regulation of angiotensin II production and angiotensin receptors in microvascular endothelial cells from bovine corpus luteum.

Authors:  K Hayashi; A Miyamoto; B Berisha; M R Kosmann; K Okuda; D Schams
Journal:  Biol Reprod       Date:  2000-01       Impact factor: 4.285

2.  Endothelin receptor mediating contraction of isolated bovine coronary artery.

Authors:  S Ishiguro; J Kawase; A Miyamoto; A Nishio
Journal:  J Vet Pharmacol Ther       Date:  2001-06       Impact factor: 1.786

3.  Angiotensin II directly induces follicle rupture and oocyte maturation in the rabbit.

Authors:  Y Yoshimura; M Karube; N Koyama; S Shiokawa; T Nanno; Y Nakamura
Journal:  FEBS Lett       Date:  1992-08-03       Impact factor: 4.124

4.  Expression and tissue concentration of vascular endothelial growth factor, its receptors, and localization in the bovine corpus luteum during estrous cycle and pregnancy.

Authors:  B Berisha; D Schams; M Kosmann; W Amselgruber; R Einspanier
Journal:  Biol Reprod       Date:  2000-10       Impact factor: 4.285

5.  Distinct cellular localization and regulation of endothelin-1 and endothelin-converting enzyme-1 expression in the bovine corpus luteum: implications for luteolysis.

Authors:  N Levy; M Gordin; R Mamluk; M Yanagisawa; M F Smith; J H Hampton; R Meidan
Journal:  Endocrinology       Date:  2001-12       Impact factor: 4.736

6.  Localization of the renin-angiotensin system in the bovine ovary: cyclic variation of the angiotensin II receptor expression.

Authors:  K H Schauser; A H Nielsen; H Winther; V Dantzer; K Poulsen
Journal:  Biol Reprod       Date:  2001-12       Impact factor: 4.285

7.  Production and localisation of angiotensin II in the bovine early corpus luteum: a possible interaction with luteal angiogenic factors and prostaglandin F2 alpha.

Authors:  S Kobayashi; B Berisha; W M Amselgruber; D Schams; A Miyamoto
Journal:  J Endocrinol       Date:  2001-08       Impact factor: 4.286

8.  Angiotensin II induces ovulation and oocyte maturation in rabbit ovaries via the AT2 receptor subtype.

Authors:  Y Yoshimura; M Karube; H Aoki; T Oda; N Koyama; A Nagai; Y Akimoto; H Hirano; Y Nakamura
Journal:  Endocrinology       Date:  1996-04       Impact factor: 4.736

9.  Constitutive endothelin-1 overexpression promotes smooth muscle cell proliferation via an external autocrine loop.

Authors:  G F Alberts; K A Peifley; A Johns; J F Kleha; J A Winkles
Journal:  J Biol Chem       Date:  1994-04-01       Impact factor: 5.157

10.  Blockage of ovulation by an angiotensin antagonist.

Authors:  A Pellicer; A Palumbo; A H DeCherney; F Naftolin
Journal:  Science       Date:  1988-06-17       Impact factor: 47.728

View more
  4 in total

1.  The Dynamics of microRNA Transcriptome in Bovine Corpus Luteum during Its Formation, Function, and Regression.

Authors:  Rreze M Gecaj; Corina I Schanzenbach; Benedikt Kirchner; Michael W Pfaffl; Irmgard Riedmaier; Ry Y Tweedie-Cullen; Bajram Berisha
Journal:  Front Genet       Date:  2017-12-15       Impact factor: 4.599

2.  Expression and localization of members of the thrombospondin family during final follicle maturation and corpus luteum formation and function in the bovine ovary.

Authors:  Bajram Berisha; Dieter Schams; Daniela Rodler; Fred Sinowatz; Michael W Pfaffl
Journal:  J Reprod Dev       Date:  2016-07-11       Impact factor: 2.214

Review 3.  Cytokines and angiogenesis in the corpus luteum.

Authors:  António M Galvão; Graça Ferreira-Dias; Dariusz J Skarzynski
Journal:  Mediators Inflamm       Date:  2013-06-11       Impact factor: 4.711

Review 4.  Microvascular endothelial cells of the corpus luteum.

Authors:  John S Davis; Bo R Rueda; Katherina Spanel-Borowski
Journal:  Reprod Biol Endocrinol       Date:  2003-11-10       Impact factor: 5.211

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.